title: Bortezomib: putting mantle cell lymphoma on death row.
authors.affiliation: Department of Malignant Haematology and Stem Cell Transplantion, The Alfred Hospital, Melbourne, Victoria, Australia. a.wei@alfred.org.au
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Wei
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Roberts
mesh_terms: D051017:Apoptosis Regulatory Proteins; D051023:BH3 Interacting Domain Death Agonist Protein; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000209:etiology; D011480:Protease Inhibitors; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D051017:Apoptosis Regulatory Proteins; D051023:BH3 Interacting Domain Death Agonist Protein; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib